Exact Mass: 288.2175

Exact Mass Matches: 288.2175

Found 240 metabolites which its exact mass value is equals to given mass value 288.2175, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Dehydroepiandrosterone

(1S,2R,5S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-one

C19H28O2 (288.2089)


Dehydroepiandrosterone (DHEA) is a natural steroid hormone produced from cholesterol by the adrenal glands. DHEA is also produced in the gonads, adipose tissue and the brain. DHEA is structurally similar to, and is a precursor of, androstenedione, testosterone, estradiol, estrone and estrogen. It is the most abundant hormone in the human body. Most of DHEA is sulfated (dehydroepiandrosterone sulfate- DEHAS) before secretion. DHEAS is the sulfated version of DHEA; - this conversion is reversibly catalyzed by sulfotransferase (SULT2A1) primarily in the adrenals, the liver, and small intestines. In blood, most DHEA is found as DHEAS with levels that are about 300 times higher than free DHEA. Blood measurements of DHEAS/DHEA are useful to detect excess adrenal activity as seen in adrenal cancer or hyperplasia, including certain forms of congenital adrenal hyperplasia. Women with polycystic ovary syndrome tend to have normal or mildly elevated levels of DHEAS. [HMDB]. Dehydroepiandrosterone is found in many foods, some of which are summer grape, quinoa, calabash, and chinese chives. Dehydroepiandrosterone (DHEA) is a natural steroid hormone produced from cholesterol by the adrenal glands. DHEA is also produced in the gonads, adipose tissue, and the brain. DHEA is structurally similar to and is a precursor of, androstenedione, testosterone, estradiol, estrone, and estrogen. It is the most abundant hormone in the human body. Most of DHEA is sulfated (dehydroepiandrosterone sulfate or DHEA-S) before secretion. DHEA-S is the sulfated version of DHEA; this conversion is reversibly catalyzed by sulfotransferase (SULT2A1) primarily in the adrenals, the liver, and small intestines. In blood, most DHEA is found as DHEA-S with levels that are about 300 times higher than free DHEA. Blood measurements of DHEA-S/DHEA are useful to detect excess adrenal activity as seen in adrenal cancer or hyperplasia, including certain forms of congenital adrenal hyperplasia. Women with polycystic ovary syndrome tend to have normal or mildly elevated levels of DHEA-S. A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones CONFIDENCE standard compound; EAWAG_UCHEM_ID 3085 D007155 - Immunologic Factors

   

Testosterone

17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one

C19H28O2 (288.2089)


Testosterone is the primary male sex hormone and anabolic steroid from the androstane class of steroids. It is the most important androgen in potency and quantity for vertebrates. In humans, testosterone plays a key role in the development of male reproductive tissues such as testes and prostate, as well as promoting secondary sexual characteristics such as increased muscle and bone mass, and the growth of body hair. In addition, testosterone is involved in health and well-being, and the prevention of osteoporosis. Testosterone exerts its action through binding to and activation of the androgen receptor. In mammals, testosterone is metabolized mainly in the liver. Approximately 50\\% of testosterone is metabolized via conjugation into testosterone glucuronide and to a lesser extent testosterone sulfate by glucuronosyltransferases and sulfotransferases. An additional 40\\% of testosterone is metabolized in equal proportions into the 17-ketosteroids androsterone and etiocholanolone via the combined actions of 5alpha- and 5beta-reductases, 3alpha-hydroxysteroid dehydrogenase, and 17beta-HSD. Like other steroid hormones, testosterone is derived from cholesterol. The first step in the biosynthesis of testosterone involves the oxidative cleavage of the side-chain of cholesterol by the cholesterol side-chain cleavage enzyme (P450scc, CYP11A1) to give pregnenolone. In the next step, two additional carbon atoms are removed by the CYP17A1 (17alpha-hydroxylase/17,20-lyase) enzyme to yield a variety of C19 steroids. In addition, the 3beta-hydroxyl group is oxidized by 3beta-hydroxysteroid dehydrogenase to produce androstenedione. In the final and rate limiting step, the C17 keto group androstenedione is reduced by 17beta-hydroxysteroid hydrogenase to yield testosterone. Testosterone is synthesized and released by the Leydig cells in the testes that lie between the tubules and comprise less than 5\\% of the total testicular volume. Testosterone diffuses into the seminiferous tubules where it is essential for maintaining spermatogenesis. Some testosterone binds to an androgen-binding protein (ABP) that is produced by the Sertoli cells and is homologous to the sex-hormone binding globulin that transports testosterone in the general circulation. The ABP carries testosterone in the testicular fluid where it maintains the activity of the accessory sex glands and may also help to retain testosterone within the tubule and bind excess free hormone. Some testosterone is converted to estradiol by Sertoli cell-derived aromatase enzyme. Leydig cell steroidogenesis is controlled primarily by luteinizing hormone with negative feedback of testosterone on the hypothalamic-pituitary axis. The requirement of spermatogenesis for high local concentrations of testosterone means that loss of androgen production is likely to be accompanied by loss of spermatogenesis. Indeed, if testicular androgen production is inhibited by the administration of exogenous androgens then spermatogenesis ceases. This is the basis of using exogenous testosterone as a male contraceptive. The largest amounts of testosterone (>95\\%) are produced by the testes in men, while the adrenal glands account for most of the remainder. Testosterone is also synthesized in far smaller total quantities in women by the adrenal glands, thecal cells of the ovaries, and, during pregnancy, by the placenta. Testosterone levels fall by about 1\\% each year in men. Therefore, with increasing longevity and the aging of the population, the number of older men with testosterone deficiency will increase substantially over the next several decades. Serum testosterone levels decrease progressively in aging men, but the rate and magnitude of decrease vary considerably. Approximately 1\\% of healthy young men have total serum testosterone levels below normal; in contrast, approximately 20\\% of healthy men over age 60 years have serum testosterone levels below normal. (PMID: 17904450, 17875487). G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03B - Androgens > G03BA - 3-oxoandrosten (4) derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

Bupivacaine

1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide

C18H28N2O (288.2202)


Bupivacaine is only found in individuals that have used or taken this drug. It is a widely used local anesthetic agent. [PubChem]Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Bupivacaine binds to the intracellular portion of sodium channels and blocks sodium influx into nerve cells, which prevents depolarization. In general, the progression of anesthesia is related to the diameter, myelination and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: (1) pain, (2) temperature, (3) touch, (4) proprioception, and (5) skeletal muscle tone. The analgesic effects of Bupivicaine are thought to potentially be due to its binding to the prostaglandin E2 receptors, subtype EP1 (PGE2EP1), which inhibits the production of prostaglandins, thereby reducing fever, inflammation, and hyperalgesia. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BB - Amides D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3305 Bupivacaine is a NMDA receptor inhibitor. Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine can be used for the research of chronic pain[1][2][3].

   

Androstanedione

(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione

C19H28O2 (288.2089)


Androstanedione belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. Thus, androstanedione is considered to be a steroid lipid molecule. Androstanedione is a very hydrophobic molecule, practically insoluble in water, and relatively neutral. Androstanedione is a steroid metabolite and a procursor of both testosterone and estrone. It is a product of enzyme 3alpha-hydroxysteroid dehydrogenase [EC 1.1.1.50] in pathway Androgen and estrogen metabolism (KEGG). [HMDB] D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   
   

Orgasteron

17alpha-Methyl-19-nortestosterone

C19H28O2 (288.2089)


ATC code: G03DC31

   

NCIOpen2_003491

(17b)-3-Methoxyestra-2,5(10)-dien-17-ol

C19H28O2 (288.2089)


   

5-Androsten-3beta-ol-16-one

3beta-Hydroxy-5-androsten-16-one; 5-Androsten-3beta-ol-16-one

C19H28O2 (288.2089)


   

4-Dihydroboldenone

(1S,2R,7R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-en-5-one

C19H28O2 (288.2089)


4-Dihydroboldenone is a metabolite of boldenone. Boldenone is an androgenic anabolic steroid (AAS) intensively used for growth promoting purposes in animals destined for meat production and as a performance enhancer in athletics. Therefore its use is officially banned either in animals intended for consumption or in humans. Because most anabolic steroids are completely metabolized and usually no parent steroid is excreted, metabolite identification is crucial to detect the illegal use of anabolic steroids either in humans or in livestock. Androgenic anabolic steroids are defined as natural, synthetic or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic and neuro-endocrine systems, the AAS have been extensively used in sports activities. (PMID: 2663904, 16195040, 16292586, 1663826, 16799097, 16888758, 16923823, 9249887) [HMDB] 4-Dihydroboldenone is a metabolite of boldenone. Boldenone is an androgenic anabolic steroid (AAS) intensively used for growth-promoting purposes in animals destined for meat production and as a performance enhancer in athletics. Therefore, its use is officially banned in both humans and in animals intended for human consumption. Because most anabolic steroids are completely metabolized and usually no parent steroid is excreted, metabolite identification is crucial to detect the illegal use of anabolic steroids either in humans or in livestock. Androgenic anabolic steroids are defined as natural, synthetic, or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic, and neuroendocrine systems, the AAS has been extensively used in sports activities (PMID: 2663904, 16195040, 16292586, 1663826, 16799097, 16888758, 16923823, 9249887). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

4-Methyl-19-nortestosterone

17-hydroxy-4,9-cyclo-9,10-secoandrost-5(10)-en-1-one

C19H28O2 (288.2089)


   

Etiocholanedione

(1S,2S,7R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,14-dione

C19H28O2 (288.2089)


Etiocholanedione is a 5-beta metabolite product of the catabolism of androgens. Etiocholanedione has been identified as a ketosteroid and isolated from the urine of healthy and diseased persons. Etiocholanedione has been identified as a metabolite of an altered androgen metabolism that eventually leads hepatocellular carcinoma to impaired hormone responsiveness in human. Etiocholanedione has been identified as a metabolite of 17alpha-hydroxyprogesterone in some patients affected by congenital adrenal hyperplasia, although it doesnt appear to account for the masculinization observed in congenital hyperplasia. Etiocholanedione can be the product of microbial contamination of urine since a few organisms are able to synthesize it using endogenous steroids as substrates. Human axillary bacteria are able to produce small amounts of etiocholanedione from testosterone. (PMID: 12161001, 13795320, 11161304, 2026727). Etiocholanedione has been found to be a metabolite of Corynebacterium (PMID: 11161304). Etiocholanedione is a 5-beta metabolite product of the catabolism of androgens. Etiocholanedione has been identified as a ketosteroid and isolated from the urine of healthy and diseased persons. Etiocholanedione has been identified as a metabolite of an altered androgen metabolism that eventually leads hepatocellular carcinoma to impaired hormone responsiveness in human. Etiocholanedione has been identified as a metabolite of 17alpha-hydroxyprogesterone in some patients affected by congenital adrenal hyperplasia, although it doesnt appear to account for the masculinization observed in congenital hyperplasia. Etiocholanedione can be the product of microbial contamination of urine since a few organisms are able to synthesize it using endogenous steroids as substrates. Human axillary bacteria are able to produce small amounts of etiocholanedione from testosterone. (PMID: 12161001, 13795320, 11161304, 2026727) [HMDB]

   

Levobupivacaine

(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide

C18H28N2O (288.2202)


Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted. pipecoloxylidide. It is the S-enantiomer of bupivacaine. Levobupivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Chirocaine. Compared to bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. It is approximately 13 per cent less potent (by molarity) than racemic bupivacaine.Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal anaesthesia in adults; and infiltration analgesia in children. Adverse drug reactions (ADRs) are rare when it is administered correctly. Most ADRs relate to administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia, however allergic reactions can rarely occur. [Wikipedia] D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BB - Amides D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

2alpha-Methyl-19-nortestosterone

17beta-Hydroxy-2alpha-methylestr-4-en-3-one

C19H28O2 (288.2089)


   

Epitestosterone

(1S,2R,10R,11S,14R,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C19H28O2 (288.2089)


Epitestosterone, or isotestosterone, also known as 17alpha-testosterone or as androst-4-en-17alpha-ol-3-one belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. Epitestosterone is an endogenous steroid and a C-17 epimer of the androgen sex hormone testosterone. It is a weak competitive antagonist of the androgen receptor (AR) and a potent 5alpha-reductase inhibitor. Structurally, epitestosterone differs from testosterone only in the configuration at the hydroxy-bearing carbon, C17. Epitestosterone is believed to form in a similar way to testosterone with 50\\% of epitestosterone production in human males taking place in the testis. Epitestosterone levels are typically highest in young males; however, by adulthood, most healthy males exhibit a testosterone to epitestosterone ratio (T/E ratio) of about 1:1 (PMID: 11901061). A study of Australian athletes found that the mean T/E ratio in the study was 1.15:1. Another study found that the max T/E ratio for the 95th percentile of athletes was 3.71:1, and the max T/E ratio for the 99th percentile was 5.25:1. Epitestosterone has not been shown to enhance athletic performance, although administration of epistestosterone can be used to mask a high level of testosterone if the standard T/E ratio test is used. As such, epitestosterone is banned by many sporting authorities as a masking agent for testosterone. Interestingly, small amounts of ethanol can elevate T/E values, with women being more susceptible (PMID: 28671321). Testosterone is a steroid hormone from the androgen group and is found in mammals, reptiles, birds, and other vertebrates. In mammals, testosterone is primarily secreted in the testicles of males and the ovaries of females, although small amounts are also secreted by the adrenal glands. It is the principal male sex hormone and an anabolic steroid. [Wikipedia]. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Dehydroandrosterone

(1S,2R,5R,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-14-one

C19H28O2 (288.2089)


Dehydroandrosterone is a normal human androgen. It has been found dehydroandrosterone and other androgens excretion is affected by seasonal rhythms changes. In a study of patients with peptic ulcer in the stage of remission, their androgen levels were higher both in summer and winter, but in the spring their levels are higher in normal subjects. There is a high correlation between Dehydroandrosterone excretion and testosterone; this ratio is also used as an aid for a better discrimination between physiologically high and pharmacologically high ratios of testosterone in sports. (PMID: 3157236, 9001956, 10774538) [HMDB] Dehydroandrosterone is a normal human androgen. It has been found dehydroandrosterone and other androgens excretion is affected by seasonal rhythms changes. In a study of patients with peptic ulcer in the stage of remission, their androgen levels were higher both in summer and winter, but in the spring their levels are higher in normal subjects. There is a high correlation between Dehydroandrosterone excretion and testosterone; this ratio is also used as an aid for a better discrimination between physiologically high and pharmacologically high ratios of testosterone in sports. (PMID: 3157236, 9001956, 10774538).

   

alpha-Amylcinnamyl isovalerate

Butanoic acid, 3-methyl-, 2-(phenylmethylene)heptyl ester

C19H28O2 (288.2089)


alpha-Amylcinnamyl isovalerate is a flavouring ingredien Flavouring ingredient

   

Testosterone-d3

14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C19H28O2 (288.2089)


   

16-Mercaptohexadecanoic acid

16-MERCAPTOHEXADECANOIC ACID

C16H32O2S (288.2123)


   

5alpha-Androstane-3,17-dione

2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,14-dione

C19H28O2 (288.2089)


   

7A-Methyl-19-nortestosterone

14-hydroxy-9,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C19H28O2 (288.2089)


   

Normethandrone

14-hydroxy-14,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C19H28O2 (288.2089)


   

Tetradecylthioacetic acid

2-(Tetradecylsulphanyl)acetic acid

C16H32O2S (288.2123)


   

(8R,9S,10R,13S,14S,17S)-17-Hydroxy-11,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one

(8R,9S,10R,13S,14S,17S)-17-Hydroxy-11,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one

C19H28O2 (288.2089)


   

(8S,9R,10S,13S,14S)-10,13-Dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione

(8S,9R,10S,13S,14S)-10,13-Dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione

C19H28O2 (288.2089)


   

Akolactone B

(-)-Akolactone B

C19H28O2 (288.2089)


   

Pipataline

Pipataline

C19H28O2 (288.2089)


A member of the class of benzodioxoles that is 1,3-benzodioxole in which the hydrogen at position 5 has been replaced by a dodec-1-en-1-yl group.

   

Gibberosin M

Gibberosin M

C19H28O2 (288.2089)


   
   

Cespitularin E

Cespitularin E

C19H28O2 (288.2089)


   

8-Deoxyserratinidine

8-Deoxyserratinidine

C18H28N2O (288.2202)


   

Oprea1_299340

Oprea1_299340

C19H28O2 (288.2089)


   
   

3beta(2-Methylacryloyloxy)-bicyclogermacren

3beta(2-Methylacryloyloxy)-bicyclogermacren

C19H28O2 (288.2089)


   

16betaH-17-hydroxy-3-oxo-19-nor-ent-kaur-4-ene

16betaH-17-hydroxy-3-oxo-19-nor-ent-kaur-4-ene

C19H28O2 (288.2089)


   

Me ester-(E)-5-Octadecene-7,9-diynoic acid

Me ester-(E)-5-Octadecene-7,9-diynoic acid

C19H28O2 (288.2089)


   

Acalycixeniolide A|acalycixeniolide-A

Acalycixeniolide A|acalycixeniolide-A

C19H28O2 (288.2089)


   

19-norisopimara-4(18),8(14),15-triene-7alpha,17-diol

19-norisopimara-4(18),8(14),15-triene-7alpha,17-diol

C19H28O2 (288.2089)


   

(3alpha,5alpha)-3-Hydroxyandrost-9(11)-en-17-one

(3alpha,5alpha)-3-Hydroxyandrost-9(11)-en-17-one

C19H28O2 (288.2089)


   

11beta-11-Hydroxy-20-nor-8,15-isopimaradien-7-one|11beta-hydroxy-20-nor-8(9),15-isopimaradien-7-one

11beta-11-Hydroxy-20-nor-8,15-isopimaradien-7-one|11beta-hydroxy-20-nor-8(9),15-isopimaradien-7-one

C19H28O2 (288.2089)


   

18-Norabieta-8,11,13-triene-4,15-diol

18-Norabieta-8,11,13-triene-4,15-diol

C19H28O2 (288.2089)


   
   

Aplysillolide B

Aplysillolide B

C19H28O2 (288.2089)


   

SCHEMBL21824308

SCHEMBL21824308

C19H28O2 (288.2089)


   

Methyl isanat

Methyl isanat

C19H28O2 (288.2089)


   

NCIOpen2_004493

NCIOpen2_004493

C19H28O2 (288.2089)


   

ent-18-hydroxykaur-16-en-15-one

ent-18-hydroxykaur-16-en-15-one

C19H28O2 (288.2089)


   

17-norphyllocladane-3,16-dione|3-Oxonorphyllocladanon

17-norphyllocladane-3,16-dione|3-Oxonorphyllocladanon

C19H28O2 (288.2089)


   

17,18-Epoxy-14-nor-8,10,15-lobatrien-13-one|17,18-epoxy-14-norloba-8,10,15-trien-13-one

17,18-Epoxy-14-nor-8,10,15-lobatrien-13-one|17,18-epoxy-14-norloba-8,10,15-trien-13-one

C19H28O2 (288.2089)


   

isoacalycixeniolide-A

isoacalycixeniolide-A

C19H28O2 (288.2089)


   

elisabethin B

elisabethin B

C19H28O2 (288.2089)


   

(2E,4E,9Z)-heptadecatrien-6-yn-1-yl acetate

(2E,4E,9Z)-heptadecatrien-6-yn-1-yl acetate

C19H28O2 (288.2089)


   

18-norabieta-8,11,13-trien-4-hydroperoxide|4-hydroperoxy-18-nor-dehydroabietane

18-norabieta-8,11,13-trien-4-hydroperoxide|4-hydroperoxy-18-nor-dehydroabietane

C19H28O2 (288.2089)


   

9,12,15-octadecatrien-6-ynoic acid methyl ester|dicranin methyl ester|Methyl-9,12,15-octadecatrien-6-ynoat

9,12,15-octadecatrien-6-ynoic acid methyl ester|dicranin methyl ester|Methyl-9,12,15-octadecatrien-6-ynoat

C19H28O2 (288.2089)


   

C18[5]-FAME

C18[5]-FAME

C19H28O2 (288.2089)


   

(S)-4-hydroxy-4-(2Z,5Z,8Z-tetradeca-2,5,8-trienyl)cyclopent-2-en-1-one|homaxinone A

(S)-4-hydroxy-4-(2Z,5Z,8Z-tetradeca-2,5,8-trienyl)cyclopent-2-en-1-one|homaxinone A

C19H28O2 (288.2089)


   

aplytandiene-1

aplytandiene-1

C19H28O2 (288.2089)


   

gifhornenolone A

gifhornenolone A

C19H28O2 (288.2089)


   

(4aR,6aS,8S,9R,11aR,11bR)-tetradecahydro-11b-methyl-4-methylidene-6a,9-methanocyclohepta[a]naphthalene-8-carboxylic acid|18-nor-ent-kaur-4(19)-en-17-oic acid

(4aR,6aS,8S,9R,11aR,11bR)-tetradecahydro-11b-methyl-4-methylidene-6a,9-methanocyclohepta[a]naphthalene-8-carboxylic acid|18-nor-ent-kaur-4(19)-en-17-oic acid

C19H28O2 (288.2089)


   

(E)-17-methyl-9-octadecen-5,7-diynoic acid|heterofibrin B1

(E)-17-methyl-9-octadecen-5,7-diynoic acid|heterofibrin B1

C19H28O2 (288.2089)


   

10-oxo-11,12-dihydrodepressin

10-oxo-11,12-dihydrodepressin

C19H28O2 (288.2089)


   

18-norabieta-8,11,13-triene-4,7beta-diol

18-norabieta-8,11,13-triene-4,7beta-diol

C19H28O2 (288.2089)


   

alpha,beta-dehydrodihydromonacolin L

alpha,beta-dehydrodihydromonacolin L

C19H28O2 (288.2089)


   

(1aR,2E,4aR,6S,7S,7aR,9Z,11aS)-1,1a,4a,5,6,7,7a,8,11,11a-decahydro-7-hydroxy-1,1,6,9-tetramethyl-4H-cyclopenta[a]cyclopropa[f] [11]annulen-4-one

(1aR,2E,4aR,6S,7S,7aR,9Z,11aS)-1,1a,4a,5,6,7,7a,8,11,11a-decahydro-7-hydroxy-1,1,6,9-tetramethyl-4H-cyclopenta[a]cyclopropa[f] [11]annulen-4-one

C19H28O2 (288.2089)


   

Methyl Octadec-cis-13-en-9,11-diynoat

Methyl Octadec-cis-13-en-9,11-diynoat

C19H28O2 (288.2089)


   

ent-3-oxa-beyer-15-en-2-one

ent-3-oxa-beyer-15-en-2-one

C19H28O2 (288.2089)


   

(4aR,7R,8S,8aR)-1,2,4a,5,6,7,8,8a-octahydro-8-[3-methylenebut-4-alyl]-4,4a,7,8-tetramethylnaphthalen-2(1H)-one

(4aR,7R,8S,8aR)-1,2,4a,5,6,7,8,8a-octahydro-8-[3-methylenebut-4-alyl]-4,4a,7,8-tetramethylnaphthalen-2(1H)-one

C19H28O2 (288.2089)


   

norcompactone

norcompactone

C19H28O2 (288.2089)


   

13,15-epoxy-19-norloba-8,10,16-trien-18-one|13,15-epoxy-19-norloba-8,10,16-triene-18-one|13,15-Epoxy-20-nor-8,10,16-lobatrien-18-one

13,15-epoxy-19-norloba-8,10,16-trien-18-one|13,15-epoxy-19-norloba-8,10,16-triene-18-one|13,15-Epoxy-20-nor-8,10,16-lobatrien-18-one

C19H28O2 (288.2089)


   

(1R,6R,10R,12R)-12-ethenyl-1,7,7,12-tetramethyl-5-oxatricyclo[8.4.0.0^{2,6]tetradec-2-en-4-one

(1R,6R,10R,12R)-12-ethenyl-1,7,7,12-tetramethyl-5-oxatricyclo[8.4.0.0^{2,6]tetradec-2-en-4-one

C19H28O2 (288.2089)


   

cannabigeroldivarin|Cannabigerovarin|CBGV

cannabigeroldivarin|Cannabigerovarin|CBGV

C19H28O2 (288.2089)


   

(2E)-1,4-dimethoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methyl-benzene|(2E)-1,4-dimethoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methylbenzene

(2E)-1,4-dimethoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methyl-benzene|(2E)-1,4-dimethoxy-2-(3,7-dimethylocta-2,6-dienyl)-6-methylbenzene

C19H28O2 (288.2089)


   

17-Hydroxy-19-norbeyer-15-en-3-on

17-Hydroxy-19-norbeyer-15-en-3-on

C19H28O2 (288.2089)


   

Fischeria A

(1R,6R,10R,12R)-12-ethenyl-1,7,7,12-tetramethyl-5-oxatricyclo[8.4.0.0^{2,6]tetradec-2-en-4-one

C19H28O2 (288.2089)


   
   

Dehydroepiandrosterone

Dehydroepiandrosterone

C19H28O2 (288.2089)


An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.269 Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.

   

Testosterone

17beta-hydroxyandrost-4-en-3-one

C19H28O2 (288.2089)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03B - Androgens > G03BA - 3-oxoandrosten (4) derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid Origin: Animal; SubCategory_DNP: The sterols, Androstanes CONFIDENCE standard compound; INTERNAL_ID 2802 CONFIDENCE standard compound; INTERNAL_ID 4160 CONFIDENCE standard compound; INTERNAL_ID 8730 Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.

   

MLS000113817-01!

MLS000113817-01!

C19H28O2 (288.2089)


   

MLS001333231-01!DEHYDROEPIANDROSTERONE53-43-0

MLS001333231-01!DEHYDROEPIANDROSTERONE53-43-0

C19H28O2 (288.2089)


   

Epitestosterone

17alpha-hydroxyandrost-4-en-3-one

C19H28O2 (288.2089)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones An androstanoid that is the C-17 epimer of testosterone.

   

Androstanedione

5alpha-androstane-3,17-dione

C19H28O2 (288.2089)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

5alpha-Androstan-3,17-dione

5alpha-Androstan-3,17-dione

C19H28O2 (288.2089)


   

bupivacaine

bupivacaine

C18H28N2O (288.2202)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BB - Amides D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent Bupivacaine is a NMDA receptor inhibitor. Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine can be used for the research of chronic pain[1][2][3].

   

5Alpha-Androstan-3,17-Dione_minor

5Alpha-Androstan-3,17-Dione_minor

C19H28O2 (288.2089)


   

5Alpha-Androstan-3,17-Dione_major

5Alpha-Androstan-3,17-Dione_major

C19H28O2 (288.2089)


   

PRASTERONE_major

PRASTERONE_major

C19H28O2 (288.2089)


   

h_10_Testosterone

h_10_Testosterone

C19H28O2 (288.2089)


   

h_7_Epitestosterone

h_7_Epitestosterone

C19H28O2 (288.2089)


   

h_51_Boldenone-m

h_51_Boldenone-m

C19H28O2 (288.2089)


   

h_193_Quinbolone_m

h_193_Quinbolone_m

C19H28O2 (288.2089)


   

h_117_1_testosterone

h_117_1_testosterone

C19H28O2 (288.2089)


   

Prasterone

Dehydroepiandrosterone

C19H28O2 (288.2089)


A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D007155 - Immunologic Factors

   

Dehydroandrosterone

Dehydroandrosterone

C19H28O2 (288.2089)


   

FEMA 2067

Butanoic acid, 3-methyl-, 2-(phenylmethylene)heptyl ester

C19H28O2 (288.2089)


   

FA 19:5

17-methyl-9E-octadecen-5,7-diynoic acid

C19H28O2 (288.2089)


   

ST 19:2;O2

17beta-hydroxy-5alpha-androst-1-en-3-one

C19H28O2 (288.2089)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   
   

tridecyl 3-mercaptopropionate

tridecyl 3-mercaptopropionate

C16H32O2S (288.2123)


   

trans-4-Propylcyclohexanecarboxylic acid 4-propylphenyl ester

trans-4-Propylcyclohexanecarboxylic acid 4-propylphenyl ester

C19H28O2 (288.2089)


   

3-Methoxy-estra-2,5(10)-dien-17-ol

3-Methoxy-estra-2,5(10)-dien-17-ol

C19H28O2 (288.2089)


   

1-BENZYL-4-PIPERIDIN-1-YLMETHYL-PIPERIDIN-4-OL

1-BENZYL-4-PIPERIDIN-1-YLMETHYL-PIPERIDIN-4-OL

C18H28N2O (288.2202)


   

2-[2-(4-tert-butylphenyl)ethyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-[2-(4-tert-butylphenyl)ethyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C18H29BO2 (288.226)


   

1-[(trans,trans)-4-Ethyl[1,1-bicyclohexyl]-4-yl]-4-fluorobenzene

1-[(trans,trans)-4-Ethyl[1,1-bicyclohexyl]-4-yl]-4-fluorobenzene

C20H29F (288.2253)


   

margaroyl chloride

margaroyl chloride

C17H33ClO (288.222)


   

(3beta)-3-Hydroxy-androst-4-en-17-one

(3beta)-3-Hydroxy-androst-4-en-17-one

C19H28O2 (288.2089)


   

trans-4-(4-propylcyclohexyl)phenyl butyrate

trans-4-(4-propylcyclohexyl)phenyl butyrate

C19H28O2 (288.2089)


   

D-(+)-Bupivacaine

(2r)-1-Butyl-n-(2,6-dimethylphenyl)piperidine-2-carboxamide

C18H28N2O (288.2202)


   

Trestolone

Trestolone

C19H28O2 (288.2089)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

Tetradcylthioacetic acid

Tetradecylthioacetic acid

C16H32O2S (288.2123)


D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants

   
   

Testosterone-[13C3]

Testosterone-[13C3]

C19H28O2 (288.2089)


   

5-Androsten-17beta-ol-3-one

17beta-Hydroxy-5-androsten-3-one

C19H28O2 (288.2089)


   

1,6-Hexamethylene bis(N,N-dimethylsemicarbazide)

1,6-Hexamethylene bis(N,N-dimethylsemicarbazide)

C12H28N6O2 (288.2274)


   

2-Ethylhexyl acrylate - styrene (1:1)

2-Ethylhexyl acrylate - styrene (1:1)

C19H28O2 (288.2089)


   

18-Methyl-19-nortestosterone

18-Methyl-19-nortestosterone

C19H28O2 (288.2089)


   

17-Hydroxyandrost-4-en-3-one

17-Hydroxyandrost-4-en-3-one

C19H28O2 (288.2089)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Androstane-3,17-dione

Androstane-3,17-dione

C19H28O2 (288.2089)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones An androstanoid that is androstane substituted by oxo groups at positions 3 and 17.

   

5-[(1E)-dodec-1-en-1-yl]-2H-1,3-benzodioxole

5-[(1E)-dodec-1-en-1-yl]-2H-1,3-benzodioxole

C19H28O2 (288.2089)


   

Normethandrone

17alpha-Methyl-19-nortestosterone

C19H28O2 (288.2089)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DC - Estren derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone ATC code: G03DC31

   

3-Carboxy-N,N,N-trimethyl-2-(octanoyloxy)propan-1-aminium

3-Carboxy-N,N,N-trimethyl-2-(octanoyloxy)propan-1-aminium

C15H30NO4+ (288.2175)


   

(1,2,6,7-3H)Testosterone

(1,2,6,7-3H)Testosterone

C19H28O2 (288.2089)


   

Teslen

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

C19H28O2 (288.2089)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03B - Androgens > G03BA - 3-oxoandrosten (4) derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

Methyl 6-(pentacyclo[6.4.0.0(2,7).0(3,6).0(9,12)]dodec-4-yl)hexanoate

Methyl 6-(pentacyclo[6.4.0.0(2,7).0(3,6).0(9,12)]dodec-4-yl)hexanoate

C19H28O2 (288.2089)


   

(3-Carboxy-2-octanoyloxypropyl)-trimethylazanium

(3-Carboxy-2-octanoyloxypropyl)-trimethylazanium

C15H30NO4+ (288.2175)


   

(8R,9S,10R,13S,14S,17S)-17-Hydroxy-11,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one

(8R,9S,10R,13S,14S,17S)-17-Hydroxy-11,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one

C19H28O2 (288.2089)


   

3-Carboxylato-2-(2-propylvaleryloxy)-N,N,N-trimethyl-1-propaneaminium

3-Carboxylato-2-(2-propylvaleryloxy)-N,N,N-trimethyl-1-propaneaminium

C15H30NO4+ (288.2175)


   

[3-Carboxy-2-(3-methylheptanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3-methylheptanoyloxy)propyl]-trimethylazanium

C15H30NO4+ (288.2175)


   

[3-Carboxy-2-(4-methylheptanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(4-methylheptanoyloxy)propyl]-trimethylazanium

C15H30NO4+ (288.2175)


   

[3-Carboxy-2-(6-methylheptanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(6-methylheptanoyloxy)propyl]-trimethylazanium

C15H30NO4+ (288.2175)


   

[3-Carboxy-2-(5-methylheptanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(5-methylheptanoyloxy)propyl]-trimethylazanium

C15H30NO4+ (288.2175)


   

(3S,10R,13S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one

(3S,10R,13S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one

C19H28O2 (288.2089)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

3-Methoxyestra-2,5(10)-dien-17beta-ol

(17b)-3-Methoxyestra-2,5(10)-dien-17-ol

C19H28O2 (288.2089)


   

17beta-Hydroxy-4-methylestr-4-en-3-one

17beta-Hydroxy-4-methylestr-4-en-3-one

C19H28O2 (288.2089)


   

5alpha-Androstan-3,7-Dione

5alpha-Androstan-3,7-Dione

C19H28O2 (288.2089)


   

[(2S)-3-carboxy-2-octanoyloxypropyl]-trimethylazanium

[(2S)-3-carboxy-2-octanoyloxypropyl]-trimethylazanium

C15H30NO4+ (288.2175)


   

[(2R)-3-carboxy-2-octanoyloxypropyl]-dimethyl-(trideuteriomethyl)azanium

[(2R)-3-carboxy-2-octanoyloxypropyl]-dimethyl-(trideuteriomethyl)azanium

C15H30NO4+ (288.2175)


   

Virormone

Virormone

C19H28O2 (288.2089)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

3-BETA-HYDROXY-5-androsten-17-one

3-BETA-HYDROXY-5-androsten-17-one

C19H28O2 (288.2089)


   

(1E,7E,11E)-1-Acetyl-3,4-epoxy-4,8,12-trimethylcyclotetrdecatriene

(1E,7E,11E)-1-Acetyl-3,4-epoxy-4,8,12-trimethylcyclotetrdecatriene

C19H28O2 (288.2089)


   

(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoic acid

(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoic acid

C19H28O2 (288.2089)


   

Methyl (2R,3R,4S)-3-(tert-butyldimethylsilyloxy)-2,4-dimethylhexanoate

Methyl (2R,3R,4S)-3-(tert-butyldimethylsilyloxy)-2,4-dimethylhexanoate

C15H32O3Si (288.2121)


   

(4AS,5S,8AS)-(+)-5beta,8Abeta-dimethyl-2-formyl-5alpha-(4-methyl-3-pentenyl)-4A,5,6,7,8,8A-hexahydronaphthalen-1(4H)-one

(4AS,5S,8AS)-(+)-5beta,8Abeta-dimethyl-2-formyl-5alpha-(4-methyl-3-pentenyl)-4A,5,6,7,8,8A-hexahydronaphthalen-1(4H)-one

C19H28O2 (288.2089)


   

Levobupivacaine

Levobupivacaine

C18H28N2O (288.2202)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01B - Anesthetics, local > N01BB - Amides D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Etiocholanedione

5B-ANDROSTANE-3,17-DIONE

C19H28O2 (288.2089)


   

17beta-Hydroxy-5beta-androst-1-en-3-one

17beta-Hydroxy-5beta-androst-1-en-3-one

C19H28O2 (288.2089)


A 3-oxo Delta(1)-steroid with 5beta-configuration formed from 17beta-hydroxyandrosta-1,4-dien-3-one by reduction across the C4-C5 double bond.

   

alpha-Amylcinnamyl isovalerate

alpha-Amylcinnamyl isovalerate

C19H28O2 (288.2089)


   

3-Hydroxyandrost-5-en-17-one

3-Hydroxyandrost-5-en-17-one

C19H28O2 (288.2089)


   

13-phenyl-9E-tridecenoic acid

13-phenyl-9E-tridecenoic acid

C19H28O2 (288.2089)


   

2-(tetradecylthio)acetic acid

2-(tetradecylthio)acetic acid

C16H32O2S (288.2123)


   

5alpha-androstane-3,17-dione

5alpha-androstane-3,17-dione

C19H28O2 (288.2089)


The 5alpha-stereoisomer of androstane-3,17-dione.

   

5beta-androstane-3,17-dione

5beta-androstane-3,17-dione

C19H28O2 (288.2089)


An androstane-3,17-dione with a 5beta-configuration.

   

Steroid 1,3-dione

Steroid 1,3-dione

C19H28O2 (288.2089)


   

Nonadecapentaenoic acid

Nonadecapentaenoic acid

C19H28O2 (288.2089)


   

1-[(1r,9s,10s,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadec-2(7)-en-6-yl]ethanone

1-[(1r,9s,10s,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadec-2(7)-en-6-yl]ethanone

C18H28N2O (288.2202)


   

n-[(1r,4s,6r,8r,9r)-4-methyl-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadec-2-en-8-yl]ethanimidic acid

n-[(1r,4s,6r,8r,9r)-4-methyl-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadec-2-en-8-yl]ethanimidic acid

C18H28N2O (288.2202)


   

13-phenyltridec-9-enoic acid

13-phenyltridec-9-enoic acid

C19H28O2 (288.2089)


   

(1r,4s,9s,10s,13s)-5,5,9,13-tetramethyl-6-oxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-7-one

(1r,4s,9s,10s,13s)-5,5,9,13-tetramethyl-6-oxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-7-one

C19H28O2 (288.2089)


   

1-{16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadec-2(7)-en-6-yl}ethanone

1-{16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadec-2(7)-en-6-yl}ethanone

C18H28N2O (288.2202)


   

7-methyl-11-methylidene-4-(pent-4-en-1-yl)-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one

7-methyl-11-methylidene-4-(pent-4-en-1-yl)-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one

C19H28O2 (288.2089)


   

7-isopropyl-1,1-dimethyl-3,4,4a,9,10,10a-hexahydro-2h-phenanthrene-3,6-diol

7-isopropyl-1,1-dimethyl-3,4,4a,9,10,10a-hexahydro-2h-phenanthrene-3,6-diol

C19H28O2 (288.2089)


   

3-[(1e)-hept-1-en-1-yl]-2-(hydroxymethyl)-4-(3-methylbut-2-en-1-yl)phenol

3-[(1e)-hept-1-en-1-yl]-2-(hydroxymethyl)-4-(3-methylbut-2-en-1-yl)phenol

C19H28O2 (288.2089)


   

(1r,4as,9r,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1,9-diol

(1r,4as,9r,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1,9-diol

C19H28O2 (288.2089)


   

[(2z,4ar,4br,8ar)-4b,8,8-trimethyl-3,4,4a,5,6,7,8a,9-octahydro-1h-phenanthren-2-ylidene]acetic acid

[(2z,4ar,4br,8ar)-4b,8,8-trimethyl-3,4,4a,5,6,7,8a,9-octahydro-1h-phenanthren-2-ylidene]acetic acid

C19H28O2 (288.2089)


   

[(2z,4ar,4br,8ar)-4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-ylidene]acetic acid

[(2z,4ar,4br,8ar)-4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-ylidene]acetic acid

C19H28O2 (288.2089)


   

3alpha-hydroxy-androst-4-ene-17-one

3α-hydroxy-androst-4-ene-17-one

C19H28O2 (288.2089)


{"Ingredient_id": "HBIN007952","Ingredient_name": "3alpha-hydroxy-androst-4-ene-17-one","Alias": "3\u03b1-hydroxy-androst-4-ene-17-one","Ingredient_formula": "C19H28O2","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31145;9781","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-hydroxyandrost-9(11)-en-17-one

NA

C19H28O2 (288.2089)


{"Ingredient_id": "HBIN008694","Ingredient_name": "3-hydroxyandrost-9(11)-en-17-one","Alias": "NA","Ingredient_formula": "C19H28O2","Ingredient_Smile": "NA","Ingredient_weight": "288.42","OB_score": "NA","CAS_id": "14043-47-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8085","PubChem_id": "NA","DrugBank_id": "NA"}

   

5 beta-androstan-3,17-dione

5β-androstan-3,17-dione

C19H28O2 (288.2089)


{"Ingredient_id": "HBIN011458","Ingredient_name": "5 beta-androstan-3,17-dione","Alias": "5\u03b2-androstan-3,17-dione","Ingredient_formula": "C19H28O2","Ingredient_Smile": "CC12CCC(=O)CC1CCC3C2CCC4(C3CCC4=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30601;1166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

5 beta-androstan-3 alpha,17 beta-diol

5β-androstan-3α,17β-diol

C19H28O2 (288.2089)


{"Ingredient_id": "HBIN011460","Ingredient_name": "5 beta-androstan-3 alpha,17 beta-diol","Alias": "5\u03b2-androstan-3\u03b1,17\u03b2-diol","Ingredient_formula": "C19H28O2","Ingredient_Smile": "CC12CCC(=O)CC1CCC3C2CCC4(C3CCC4=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30599;1164","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

5,5,9,13-tetramethyl-6-oxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-7-one

5,5,9,13-tetramethyl-6-oxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-7-one

C19H28O2 (288.2089)


   

7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,7a-tetrahydro-2-benzofuran-1-one

7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,7a-tetrahydro-2-benzofuran-1-one

C19H28O2 (288.2089)


   

(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-peroxol

(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-peroxol

C19H28O2 (288.2089)


   

1-[(1r,5z,9s,10s)-6,10-dimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-10-yl]pentane-1,4-dione

1-[(1r,5z,9s,10s)-6,10-dimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-10-yl]pentane-1,4-dione

C19H28O2 (288.2089)


   

5-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one

5-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one

C19H28O2 (288.2089)


   

(1r,4as,10ar)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-ol

(1r,4as,10ar)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-ol

C19H28O2 (288.2089)


   

(7e)-7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,7a-tetrahydro-2-benzofuran-1-one

(7e)-7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,7a-tetrahydro-2-benzofuran-1-one

C19H28O2 (288.2089)


   

methyl (9z,12z,15z)-octadeca-9,12,15-trien-6-ynoate

methyl (9z,12z,15z)-octadeca-9,12,15-trien-6-ynoate

C19H28O2 (288.2089)


   

(2e,4e)-heptadeca-2,4,9-trien-6-yn-1-yl acetate

(2e,4e)-heptadeca-2,4,9-trien-6-yn-1-yl acetate

C19H28O2 (288.2089)


   

1-[(1s,5e,9r,10r)-6,10-dimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-10-yl]pentane-1,4-dione

1-[(1s,5e,9r,10r)-6,10-dimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-10-yl]pentane-1,4-dione

C19H28O2 (288.2089)


   

(5s)-5-methyl-3-[(1e,11e)-tetradeca-1,11,13-trien-1-yl]-5h-furan-2-one

(5s)-5-methyl-3-[(1e,11e)-tetradeca-1,11,13-trien-1-yl]-5h-furan-2-one

C19H28O2 (288.2089)


   

(4s,4as,11ar)-7-methyl-11-methylidene-4-(pent-4-en-1-yl)-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one

(4s,4as,11ar)-7-methyl-11-methylidene-4-(pent-4-en-1-yl)-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one

C19H28O2 (288.2089)


   

(4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-ylidene)acetic acid

(4b,8,8-trimethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-ylidene)acetic acid

C19H28O2 (288.2089)


   

(1r,4as,4bs,7r,10as)-7-ethenyl-1-(hydroxymethyl)-4a,7-dimethyl-2,4,4b,5,6,9,10,10a-octahydro-1h-phenanthren-3-one

(1r,4as,4bs,7r,10as)-7-ethenyl-1-(hydroxymethyl)-4a,7-dimethyl-2,4,4b,5,6,9,10,10a-octahydro-1h-phenanthren-3-one

C19H28O2 (288.2089)


   

(3s,4ar,10as)-7-isopropyl-1,1-dimethyl-3,4,4a,9,10,10a-hexahydro-2h-phenanthrene-3,6-diol

(3s,4ar,10as)-7-isopropyl-1,1-dimethyl-3,4,4a,9,10,10a-hexahydro-2h-phenanthrene-3,6-diol

C19H28O2 (288.2089)


   

4-[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-2-methylidenebutanal

4-[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]-2-methylidenebutanal

C19H28O2 (288.2089)


   

6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one

6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one

C19H28O2 (288.2089)


   

(2e,4e,9z)-heptadeca-2,4,9-trien-6-yn-1-yl acetate

(2e,4e,9z)-heptadeca-2,4,9-trien-6-yn-1-yl acetate

C19H28O2 (288.2089)


   

7-ethenyl-1-(hydroxymethyl)-4a,7-dimethyl-2,4,4b,5,6,9,10,10a-octahydro-1h-phenanthren-3-one

7-ethenyl-1-(hydroxymethyl)-4a,7-dimethyl-2,4,4b,5,6,9,10,10a-octahydro-1h-phenanthren-3-one

C19H28O2 (288.2089)


   

(4e,6s,11r)-6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one

(4e,6s,11r)-6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one

C19H28O2 (288.2089)


   

(1s,3as,4ar)-1-hydroxy-1-isopropyl-3a,5-dimethyl-2h,3h,4h,4ah,8ah,10h,10ah-cyclohexa[f]azulen-9-one

(1s,3as,4ar)-1-hydroxy-1-isopropyl-3a,5-dimethyl-2h,3h,4h,4ah,8ah,10h,10ah-cyclohexa[f]azulen-9-one

C19H28O2 (288.2089)


   

(1r,4s,5s,9s,10s,13r)-5-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one

(1r,4s,5s,9s,10s,13r)-5-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one

C19H28O2 (288.2089)


   

(3as,6as)-2-[(1e,3r)-3-hydroxy-2,6-dimethylhepta-1,5-dien-1-yl]-3,6a-dimethyl-3a,4,5,6-tetrahydropentalen-1-one

(3as,6as)-2-[(1e,3r)-3-hydroxy-2,6-dimethylhepta-1,5-dien-1-yl]-3,6a-dimethyl-3a,4,5,6-tetrahydropentalen-1-one

C19H28O2 (288.2089)


   

5-(dodec-1-en-1-yl)-2h-1,3-benzodioxole

5-(dodec-1-en-1-yl)-2h-1,3-benzodioxole

C19H28O2 (288.2089)


   

(3as,6as)-2-[(1e)-3-hydroxy-2,6-dimethylhepta-1,5-dien-1-yl]-3,6a-dimethyl-3a,4,5,6-tetrahydropentalen-1-one

(3as,6as)-2-[(1e)-3-hydroxy-2,6-dimethylhepta-1,5-dien-1-yl]-3,6a-dimethyl-3a,4,5,6-tetrahydropentalen-1-one

C19H28O2 (288.2089)


   

(1r,4r,5r,9r,10s,13r)-13-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-6-one

(1r,4r,5r,9r,10s,13r)-13-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-6-one

C19H28O2 (288.2089)


   

7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1,9-diol

7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1,9-diol

C19H28O2 (288.2089)


   

3-(hept-1-en-1-yl)-2-(hydroxymethyl)-4-(3-methylbut-2-en-1-yl)phenol

3-(hept-1-en-1-yl)-2-(hydroxymethyl)-4-(3-methylbut-2-en-1-yl)phenol

C19H28O2 (288.2089)


   

7-methyl-11-methylidene-4-(pent-3-en-1-yl)-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one

7-methyl-11-methylidene-4-(pent-3-en-1-yl)-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one

C19H28O2 (288.2089)


   

4-(1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl)-2-methylidenebutanal

4-(1,2,4a,5-tetramethyl-7-oxo-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl)-2-methylidenebutanal

C19H28O2 (288.2089)


   

(4e,6r,11s)-6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one

(4e,6r,11s)-6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one

C19H28O2 (288.2089)


   

2-pentyl-5-[(5-pentylfuran-2-yl)methyl]furan

2-pentyl-5-[(5-pentylfuran-2-yl)methyl]furan

C19H28O2 (288.2089)


   

2-isopropyl-8,8-dimethyl-5,6,7,8a,9,10-hexahydro-4bh-phenanthrene-3,4-diol

2-isopropyl-8,8-dimethyl-5,6,7,8a,9,10-hexahydro-4bh-phenanthrene-3,4-diol

C19H28O2 (288.2089)


   

5-[(4z,7z)-trideca-4,7-dien-1-yl]benzene-1,3-diol

5-[(4z,7z)-trideca-4,7-dien-1-yl]benzene-1,3-diol

C19H28O2 (288.2089)


   

(1s,3s,3as,5s,7ar)-1,5-dimethyl-3-(2-methylprop-1-en-1-yl)-3a-(2-methylprop-2-enoyl)-hexahydro-1h-inden-4-one

(1s,3s,3as,5s,7ar)-1,5-dimethyl-3-(2-methylprop-1-en-1-yl)-3a-(2-methylprop-2-enoyl)-hexahydro-1h-inden-4-one

C19H28O2 (288.2089)


   

cannabigerovarin

cannabigerovarin

C19H28O2 (288.2089)


   

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,5-dimethoxy-3-methylbenzene

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,5-dimethoxy-3-methylbenzene

C19H28O2 (288.2089)


   

(1s,4r,9r,10s,13r)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-6,14-dione

(1s,4r,9r,10s,13r)-5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-6,14-dione

C19H28O2 (288.2089)


   

7-ethenyl-8a-hydroxy-4a,7-dimethyl-1-methylidene-octahydro-2h-phenanthren-9-one

7-ethenyl-8a-hydroxy-4a,7-dimethyl-1-methylidene-octahydro-2h-phenanthren-9-one

C19H28O2 (288.2089)


   

(3ar,6r,7z)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-3,3a,4,6-tetrahydro-2-benzofuran-5-one

(3ar,6r,7z)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-3,3a,4,6-tetrahydro-2-benzofuran-5-one

C19H28O2 (288.2089)


   

12-ethenyl-1,7,7,12-tetramethyl-5-oxatricyclo[8.4.0.0²,⁶]tetradec-2-en-4-one

12-ethenyl-1,7,7,12-tetramethyl-5-oxatricyclo[8.4.0.0²,⁶]tetradec-2-en-4-one

C19H28O2 (288.2089)


   

(4s,4as,11ar)-7-methyl-11-methylidene-4-[(3z)-pent-3-en-1-yl]-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one

(4s,4as,11ar)-7-methyl-11-methylidene-4-[(3z)-pent-3-en-1-yl]-1h,4h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-3-one

C19H28O2 (288.2089)


   

7-ethenyl-5-hydroxy-1,1,7-trimethyl-3,4,4a,5,6,8,10,10a-octahydro-2h-phenanthren-9-one

7-ethenyl-5-hydroxy-1,1,7-trimethyl-3,4,4a,5,6,8,10,10a-octahydro-2h-phenanthren-9-one

C19H28O2 (288.2089)


   

7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-ol

7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-ol

C19H28O2 (288.2089)


   

2-(3-hydroxy-2,6-dimethylhepta-1,5-dien-1-yl)-3,6a-dimethyl-3a,4,5,6-tetrahydropentalen-1-one

2-(3-hydroxy-2,6-dimethylhepta-1,5-dien-1-yl)-3,6a-dimethyl-3a,4,5,6-tetrahydropentalen-1-one

C19H28O2 (288.2089)


   

2-methyl-6-(4-methylphenyl)hept-2-en-1-yl 2-methylpropanoate

2-methyl-6-(4-methylphenyl)hept-2-en-1-yl 2-methylpropanoate

C19H28O2 (288.2089)


   

(3ar,6r,7e)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-3,3a,4,6-tetrahydro-2-benzofuran-5-one

(3ar,6r,7e)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-3,3a,4,6-tetrahydro-2-benzofuran-5-one

C19H28O2 (288.2089)


   

(1r,6r,10r,12r)-12-ethenyl-1,7,7,12-tetramethyl-5-oxatricyclo[8.4.0.0²,⁶]tetradec-2-en-4-one

(1r,6r,10r,12r)-12-ethenyl-1,7,7,12-tetramethyl-5-oxatricyclo[8.4.0.0²,⁶]tetradec-2-en-4-one

C19H28O2 (288.2089)


   

(2z,6s)-2-methyl-6-(4-methylphenyl)hept-2-en-1-yl 2-methylpropanoate

(2z,6s)-2-methyl-6-(4-methylphenyl)hept-2-en-1-yl 2-methylpropanoate

C19H28O2 (288.2089)


   

(5z,8z,11z,14z,17z)-nonadeca-5,8,11,14,17-pentaenoic acid

(5z,8z,11z,14z,17z)-nonadeca-5,8,11,14,17-pentaenoic acid

C19H28O2 (288.2089)


   

1-{6,10-dimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-10-yl}pentane-1,4-dione

1-{6,10-dimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-10-yl}pentane-1,4-dione

C19H28O2 (288.2089)


   

14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-4-en-6-one

14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-4-en-6-one

C19H28O2 (288.2089)


   

(4b,8,8-trimethyl-3,4,4a,5,6,7,8a,9-octahydro-1h-phenanthren-2-ylidene)acetic acid

(4b,8,8-trimethyl-3,4,4a,5,6,7,8a,9-octahydro-1h-phenanthren-2-ylidene)acetic acid

C19H28O2 (288.2089)


   

nonadeca-5,8,11,14,17-pentaenoic acid

nonadeca-5,8,11,14,17-pentaenoic acid

C19H28O2 (288.2089)


   

(4r,7r,8r,9s,12r)-9-[(2r)-6-methylhept-5-en-2-yl]-3-oxatricyclo[5.4.1.0⁴,¹²]dodeca-1(11),5-dien-8-ol

(4r,7r,8r,9s,12r)-9-[(2r)-6-methylhept-5-en-2-yl]-3-oxatricyclo[5.4.1.0⁴,¹²]dodeca-1(11),5-dien-8-ol

C19H28O2 (288.2089)


   

7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,6-tetrahydro-2-benzofuran-5-one

7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,6-tetrahydro-2-benzofuran-5-one

C19H28O2 (288.2089)


   

methyl octadeca-9,12,15-trien-6-ynoate

methyl octadeca-9,12,15-trien-6-ynoate

C19H28O2 (288.2089)


   

(4e,11s)-6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one

(4e,11s)-6-hydroxy-4,15,15-trimethyl-8-methylidenebicyclo[9.3.1]pentadeca-1(14),4-dien-2-one

C19H28O2 (288.2089)


   

n-[(1r,2r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-10-en-11-yl]ethanimidic acid

n-[(1r,2r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-10-en-11-yl]ethanimidic acid

C18H28N2O (288.2202)


   

(1s,4r,9r,10r,13r,14s)-9-methyl-5-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylic acid

(1s,4r,9r,10r,13r,14s)-9-methyl-5-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylic acid

C19H28O2 (288.2089)


   

13-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-6-one

13-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-6-one

C19H28O2 (288.2089)


   

1-(3,7-dimethylocta-2,6-dien-1-yl)-2,5-dimethoxy-3-methylbenzene

1-(3,7-dimethylocta-2,6-dien-1-yl)-2,5-dimethoxy-3-methylbenzene

C19H28O2 (288.2089)


   

(4as,5s,7r,10as)-7-ethenyl-5-hydroxy-1,1,7-trimethyl-3,4,4a,5,6,8,10,10a-octahydro-2h-phenanthren-9-one

(4as,5s,7r,10as)-7-ethenyl-5-hydroxy-1,1,7-trimethyl-3,4,4a,5,6,8,10,10a-octahydro-2h-phenanthren-9-one

C19H28O2 (288.2089)


   

7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-peroxol

7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-peroxol

C19H28O2 (288.2089)


   

(1r,9r,10s,13s,14s)-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-4-en-6-one

(1r,9r,10s,13s,14s)-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-4-en-6-one

C19H28O2 (288.2089)


   

(4as,4br,7s,8ar,10as)-7-ethenyl-8a-hydroxy-4a,7-dimethyl-1-methylidene-octahydro-2h-phenanthren-9-one

(4as,4br,7s,8ar,10as)-7-ethenyl-8a-hydroxy-4a,7-dimethyl-1-methylidene-octahydro-2h-phenanthren-9-one

C19H28O2 (288.2089)


   

(1r,4as,7r,10as)-7-ethenyl-1-(hydroxymethyl)-4a,7-dimethyl-2,4,4b,5,6,9,10,10a-octahydro-1h-phenanthren-3-one

(1r,4as,7r,10as)-7-ethenyl-1-(hydroxymethyl)-4a,7-dimethyl-2,4,4b,5,6,9,10,10a-octahydro-1h-phenanthren-3-one

C19H28O2 (288.2089)


   

5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-6,14-dione

5,5,9-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-6,14-dione

C19H28O2 (288.2089)


   

5-(trideca-4,7-dien-1-yl)benzene-1,3-diol

5-(trideca-4,7-dien-1-yl)benzene-1,3-diol

C19H28O2 (288.2089)


   

(1s,4as,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-peroxol

(1s,4as,10ar)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-peroxol

C19H28O2 (288.2089)


   

(1r,8r,9s)-9-hydroxy-12-isopropyl-1,8-dimethyltricyclo[9.3.0.0³,⁷]tetradeca-3(7),11-dien-4-one

(1r,8r,9s)-9-hydroxy-12-isopropyl-1,8-dimethyltricyclo[9.3.0.0³,⁷]tetradeca-3(7),11-dien-4-one

C19H28O2 (288.2089)


   

(3as,7z,7as)-7-ethylidene-6-[(1r)-1,3,3-trimethylcyclohexyl]-3,3a,4,7a-tetrahydro-2-benzofuran-1-one

(3as,7z,7as)-7-ethylidene-6-[(1r)-1,3,3-trimethylcyclohexyl]-3,3a,4,7a-tetrahydro-2-benzofuran-1-one

C19H28O2 (288.2089)